Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Medicinas Complementares
Métodos Terapêuticos e Terapias MTCI
Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
2.
Am Fam Physician ; 102(10): 603-612, 2020 11 15.
Artigo em Inglês | MEDLINE | ID: mdl-33179890

RESUMO

Nonalcoholic fatty liver disease (NAFLD) is the most common form of liver disease in the United States, affecting up to 30% of adults. There are two forms of NAFLD: nonalcoholic fatty liver (NAFL), defined as 5% or greater hepatic steatosis without hepatocellular injury or fibrosis, and nonalcoholic steatohepatitis (NASH), defined as 5% or greater hepatic steatosis plus hepatocellular injury and inflammation, with or without fibrosis. Individuals with obesity are at highest risk of NAFLD. Other established risk factors include metabolic syndrome and type 2 diabetes mellitus. Although NAFLD is common and typically asymptomatic, screening is not currently recommended, even in high-risk patients. NAFLD should be suspected in patients with elevated liver enzymes or hepatic steatosis on abdominal imaging that are found incidentally. Once other causes, such as excessive alcohol use and hepatotoxic medications, are excluded in these patients, risk scores or elastography tests can be used to identify those who are likely to have fibrosis that will progress to cirrhosis. Liver biopsy should be considered for patients at increased risk of fibrosis and when other liver disorders cannot be excluded with noninvasive tests. Weight loss through diet and exercise is the primary treatment for NAFLD. Other treatments, such as bariatric surgery, vitamin E supplements, and pharmacologic therapy with thiazolidinediones or glucagon-like peptide-1 analogues, have shown potential benefit; however, data are limited, and these therapies are not considered routine treatments. NAFL typically follows an indolent course, whereas patients with NASH are at higher risk of death from cardiovascular disease, cancer, and end-stage liver disease.


Assuntos
Dieta Redutora , Exercício Físico , Hepatopatia Gordurosa não Alcoólica/terapia , Alanina Transaminase/sangue , Aspartato Aminotransferases/sangue , Cirurgia Bariátrica , Biópsia , Técnicas de Imagem por Elasticidade , Peptídeo 1 Semelhante ao Glucagon/agonistas , Humanos , Hipoglicemiantes/uso terapêutico , Fígado/diagnóstico por imagem , Fígado/patologia , Cirrose Hepática/sangue , Cirrose Hepática/diagnóstico por imagem , Imageamento por Ressonância Magnética , Hepatopatia Gordurosa não Alcoólica/sangue , Hepatopatia Gordurosa não Alcoólica/diagnóstico , Hepatopatia Gordurosa não Alcoólica/patologia , Encaminhamento e Consulta , Medição de Risco , Albumina Sérica/metabolismo , Índice de Gravidade de Doença , Tiazolidinedionas/uso terapêutico , Vitamina E/uso terapêutico , Vitaminas/uso terapêutico
3.
J Fam Pract ; 66(12): 743-747, 2017 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-29202144

RESUMO

With the growing number of DOs and the high utilization of osteopathic manipulative treatment (OMT), it is important for all physicians to understand the role OMT can play in the treatment of conditions ranging from low back pain to irritable bowel syndrome so that patients may be offered, or referred for, the treatment when appropriate.


Assuntos
Cefaleia/terapia , Doenças Inflamatórias Intestinais/terapia , Dor Lombar/terapia , Osteopatia , Humanos , Manejo da Dor
4.
J Am Osteopath Assoc ; 113(10): 768-75, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24084803

RESUMO

The number of US older adults with dementia is expected to grow over the next several decades. For instance, the number of persons with Alzheimer disease is predicted to increase by 50% by 2030. Physicians commonly come into contact with patients who have dementia and, as such, need to understand its varied presentation. In the current review, the most common types of dementia, including Alzheimer disease, frontotemporal dementia, dementia due to vascular disease, and several others, are described. Characteristics and etiologic findings of cortical and subcortical dementias are differentiated, and cognitive profiles and symptoms of specific types of dementia are reviewed. An osteopathic approach to care, focusing on establishing a relationship with patients and their families, is also discussed.


Assuntos
Cuidadores , Demência/diagnóstico , Demência/terapia , Medicina de Família e Comunidade/métodos , Medicina Osteopática/métodos , Médicos Osteopáticos , Humanos , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA